Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M938Revenue $M14.2Net Margin (%)-787.6Z-Score12.9
Enterprise Value $M660EPS $-3.3Operating Margin %-635.0F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-787.6Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %-9.1Quick Ratio10.4Cash flow > EarningsY
Price/Sales55.95-y EBITDA Growth Rate %25.2Current Ratio10.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-38.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-45.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.7ROI % (ttm)-300.9Gross Margin Increase y-yN

Gurus Latest Trades with SRPT

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
SRPTGeorge Soros 2014-06-30 Add0.14%$22.18 - $38.91
$ 22.93-28%Add 2620%680,000
SRPTGeorge Soros 2014-03-31 Reduce-0.04%$17.91 - $30.29
$ 22.93-10%Reduce -89.27%25,000
SRPTGeorge Soros 2013-12-31 Reduce-0.22%$12.89 - $53.81
$ 22.93-22%Reduce -64.98%233,000
SRPTGeorge Soros 2013-09-30 Add0.12%$30.906 - $47.97
$ 22.93-40%Add 56.28%665,274
SRPTGeorge Soros 2013-03-31 Add0.08%$23.97 - $36.95
$ 22.93-20%Add 82.54%413,329
SRPTGeorge Soros 2012-12-31 Add0.05%$14.99 - $44.93
$ 22.93-14%Add 184.13%226,429
SRPTJean-Marie Eveillard 2012-03-31 Sold Out $4.5 - $9.6
$ 22.93278%Sold Out0
SRPTJean-Marie Eveillard 2011-12-31 Reduce$3.24 - $6.54
$ 22.93355%Reduce -83.33%50,000
SRPTJean-Marie Eveillard 2011-09-30 Add$6.3 - $9.9
$ 22.93190%Add 50%300,000
SRPTJean-Marie Eveillard 2011-06-30 Buy $8.1 - $11.22
$ 22.93137%New holding, 200000 sh.200,000
SRPTGeorge Soros 2006-03-31 Buy 0.08%$24.54 - $50.45
$ 22.93-45%New holding, 308100 sh.308,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SRPT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SRPT George Soros 2014-06-30680,0001.670.15+2620%
Premium Most recent portfolio changes are included for Premium Members only!

SRPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CHASE ANTHONY RDirector 2013-11-14Buy10,000$13.9564.37view
Aphale JayantSVP Technical Operations 2013-11-12Sell15,933$12.5682.56view
BEHRENS M KATHLEENDirector 2013-09-16Buy6,500$37.04-38.09view
HODGMAN JOHNDirector 2013-09-03Sell5,556$34.97-34.43view
CHASE ANTHONY RDirector 2013-08-22Buy3,500$32.68-29.83view
Mahatme SandeshSenior Vice President, CFO 2013-08-20Buy5,000$31.1-26.27view
Price Ben GilDirector 2013-08-19Buy500$31.18-26.46view
CHASE ANTHONY RDirector 2013-06-14Buy10,000$38.5-40.44view
CHASE ANTHONY RDirector 2012-11-28Sell10,000$29.46-22.17view
CHASE ANTHONY RDirector 2012-11-14Sell10,000$25.7-10.78view

Press Releases about SRPT :

    Quarterly/Annual Reports about SRPT:

    News about SRPT:

    Articles On GuruFocus.com
    Insiders Are Buying Fate Therapeutics Oct 09 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Feb 16 2013 

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Aug 29 2014
    BioCryst to Launch NHP Ebola Drug Safety, Efficacy Studies 'Within Weeks' Aug 29 2014
    Sarepta Therapeutics to Present Company Overview at Upcoming Conferences Aug 28 2014
    SAREPTA THERAPEUTICS, INC. Financials Aug 26 2014
    How Will We Know If The Ebola Drugs Worked? Aug 26 2014
    Sarepta Enters into Partnership with Flagship Biosciences to Digitally Automate the Measurement of... Aug 21 2014
    [$$] Cash In on Taser's Gains With Moves in Options Aug 19 2014
    As Ebola Outbreak Expands, These Experimental Drugs Could See Action Aug 18 2014
    Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss Aug 12 2014
    [video] Biotechs race for Ebola cure Aug 11 2014
    Biotechs That Might Benefit From Ebola Research Aug 11 2014
    Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars Aug 08 2014
    Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT) Aug 08 2014
    FDA Moves On Tekmira's Ebola Drug While Sarepta's Sits Unused Aug 07 2014
    [video] Ebola not easily spread: Doctor Aug 07 2014
    [video] Pharma companies rush to help Ebola Aug 07 2014
    Looking to trade on Ebola? Beware Aug 07 2014
    Sarepta Therapeutics Inc Earnings Call scheduled for 8:00 am ET today Aug 07 2014
    SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 07 2014
    Sarepta Therapeutics Announces Second Quarter 2014 Financial Results and Recent Corporate... Aug 07 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial